David A. Siegel Lannett CO Inc Transaction History

Two Sigma Advisers, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.45 - $0.86 $27,358 - $52,285	-60,797 Reduced 21.24%	225,400 $117,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.63 $122,223 - $167,392	-265,703 Reduced 48.14%	286,197 $129,000
Q2 2022 Aug 15, 2022	SELL	$0.47 - $0.87 $73,226 - $135,546	-155,800 Reduced 22.01%	551,900 $320,000
Q1 2022 May 16, 2022	BUY	$0.75 - $1.77 $34,200 - $80,712	45,600 Added 6.89%	707,700 $558,000
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.93 $985,764 - $1.85 Million	631,900 Added 2092.38%	662,100 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.83 $87,882 - $145,866	30,200 New	30,200 $91,000
Q4 2020 Feb 16, 2021	SELL	$5.75 - $7.13 $204,125 - $253,115	-35,500 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.9 - $7.12 $231,280 - $336,064	-47,200 Reduced 57.07%	35,500 $217,000
Q2 2020 Aug 14, 2020	BUY	$6.43 - $9.86 $16,075 - $24,650	2,500 Added 3.12%	82,700 $600,000
Q1 2020 May 15, 2020	SELL	$6.36 - $10.05 $805,812 - $1.27 Million	-126,700 Reduced 61.24%	80,200 $557,000
Q4 2019 Feb 14, 2020	BUY	$8.49 - $12.81 $1.13 Million - $1.7 Million	132,600 Added 178.47%	206,900 $1.83 Million
Q3 2019 Nov 14, 2019	SELL	$5.58 - $14.47 $584,226 - $1.52 Million	-104,700 Reduced 58.49%	74,300 $832,000
Q2 2019 Aug 14, 2019	BUY	$5.22 - $9.08 $39,150 - $68,100	7,500 Added 4.37%	179,000 $1.09 Million
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $425,860 - $781,672	79,600 Added 86.62%	171,500 $1.35 Million
Q4 2018 Feb 14, 2019	BUY	$3.43 - $6.19 $315,217 - $568,861	91,900 New	91,900 $456,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.